A Comparative Analysis of D-Dimer and Interleukin-6 Levels in COVID-19 Survivors: Implications for Long-term Outcomes
- DOI
- 10.2991/978-94-6463-324-5_3How to use a DOI?
- Keywords
- Prosthetic Hand; Machine Learning; Pattern Recognition; EMG
- Abstract
Several studies have investigated the association between D-Dimer and Interleukin-6 levels in COVID-19 patients. Nikkhoo et al. conducted a longitudinal prospective cohort study to investigate the association between IL-6 levels and disease severity among COVID-19 patients. They found that elevated IL-6 levels were associated with increased disease severity and mortality. Huang et al. investigated the association between D-Dimer levels and disease severity among COVID-19 patients using a retrospective cohort design. They found that elevated D-Dimer levels were associated with increased disease severity, mortality, and thrombotic events. A systematic review and meta-analysis by Lippi et al. investigated the relationship between D-Dimer and Interleukin-6 levels in COVID-19 patients. They found that both biomarkers were significantly elevated in COVID-19 patients compared to healthy controls. Moreover, they found that D-Dimer levels were significantly higher in severe COVID-19 patients compared to non-severe patients. Similarly, IL-6 levels were significantly higher in severe COVID-19 patients compared to non-severe patients. Few studies have investigated the longitudinal changes in D-Dimer and Interleukin-6 levels in COVID-19 survivors. Nikkhoo et al. found that IL-6 levels decreased over time in COVID-19 survivors. However, it is unclear how D-Dimer levels evolve in COVID-19 survivors over time. The findings from these studies have several implications for long-term outcomes of COVID-19. Firstly, monitoring D-Dimer and Interleukin-6 levels may aid in assessing disease progression and response to treatment. Second, studying these biomarkers could contribute to the development of targeted therapies for COVID-19 survivors.
- Copyright
- © 2023 The Author(s)
- Open Access
- Open Access This chapter is licensed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), which permits any noncommercial use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license and indicate if changes were made.
Cite this article
TY - CONF AU - Anik Handayati AU - Jusak Nugraha AU - Rahajoe Imam Santosa PY - 2023 DA - 2023/12/23 TI - A Comparative Analysis of D-Dimer and Interleukin-6 Levels in COVID-19 Survivors: Implications for Long-term Outcomes BT - Proceedings of the 6th International Conference of Health Polytechnic Surabaya (ICoHPS 2023) PB - Atlantis Press SP - 14 EP - 22 SN - 2468-5739 UR - https://doi.org/10.2991/978-94-6463-324-5_3 DO - 10.2991/978-94-6463-324-5_3 ID - Handayati2023 ER -